NCT00309075View on ClinicalTrials.gov

Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis in the Calf and/or Pedal Arteries

PHASE3CompletedINTERVENTIONAL

Enrollment

126

Participants

Timeline

Start Date

December 31, 2003

Study Completion Date

November 30, 2004

Conditions

Stenosis

Interventions

DRUG

Gadopentetate dimeglumine (Magnevist)

Gadopentetate dimeglumine (Magnevist Injection), approximately 0.1mmol/kg body weight, single intravenous administration on the study day

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY